Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Caerus Discovery LLC
Profile last edited on: 11/8/2016      CAGE: 52FJ3      UEI:

Business Identifier: New therapeutic targets for treatment of human diseases: infectious, inflammatory, metabolic, neurological and malignant
Year Founded
2008
First Award
2014
Latest Award
2014
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10900 University Boulevard
Manassas, VA 20110
   N/A
   N/A
   www.caerusdiscovery.com/
Location: Single
Congr. District: 10
County: Manassas

Public Profile

Caerus Discovery, LLC is a privately owned development stage company focused on discovery of new molecular targets for cancer, autoimmune, inflammatory and infectious diseases, as well as development of its second-generation subtractive immunization platform to unravel novel targets and molecules for diagnostic and therapeutic applications.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$224,475
Phase II Dollars
$0
Total Awarded
$224,475

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2014 1 NIH $224,475
Project Title: Monoclonal Antibody Targeting Cancer Stem Cells

Key People / Management

  Cohava Gelber -- Co-Founder, Executive Chairperson

  Vanitha Khera

Company News

There are no news available.